My Companies
Notification
Account
Log Out
Back

Bharat Parenterals Subsidiary Receives USFDA EIR For Vadodara Injectable Facility

5 November 2026
Bharat Parenterals Ltd.

Innoxel Lifesciences received USFDA Establishment Inspection Report dated November 4 for unannounced April 13-20 pre-approval inspection of general injectable at Vadodara facility; inspection closed with facility deemed ready for commercial operations, second EIR after July 2025.

Recent Events

21 October 2026

Bharat Parenterals Commences US Commercial Supply Via Subsidiary Innoxel Lifesciences
29 September 2026

Bharat Parenterals Board Approves ₹139 Crore Preferential Share Allotment
11 August 2026

Bharat Parenterals Approves ₹300 Crore Biologics CDMO Facility Expansion

Real time WhatsApp alerts using AI.

Get features of

  • Instant Notifications
  • Competitive Advantage
  • Critical Alerts
Signup or Sign in

Company Information